![](/img/cover-not-exists.png)
Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial
Lavigne-Lissalde, G., Aya, A. G., Mercier, F. J., Roger-Christoph, S., Chauleur, C., Morau, E., Ducloy-Bouthors, A. S., Mignon, A., Raucoules, M., Bongain, A., Boehlen, F., de Moerloose, P., Bouvet, SVolume:
13
Language:
english
Journal:
Journal of Thrombosis and Haemostasis
DOI:
10.1111/jth.12844
Date:
April, 2015
File:
PDF, 323 KB
english, 2015